Paul Sauter

Director Chemistry & Bioconjugation at Velabs Therapeutics

Paul Sauter is currently the Director Chemistry & Bioconjugation at VERAXA Biotech GmbH since January 2020. Prior to this role, they were the Head Of Chemistry at EMBL from May 2016 to December 2019. Paul Sauter obtained their Ph.D. in Organic Chemistry from Karlsruhe Institute of Technology (KIT) in March 2016.

Links

Previous companies

Org chart

View in org chart

Manager

Arne Faiss

CEO

Peers

Christine Köhler

Head Of Antibody Engineering

Heinz Schwer Ph.D.

Managing Director/ Chief Business Officer

Marian Weiss

Director Microfluidics

Reports

Markus Strubel

Chemical Technical Assistant

View in org chart

Timeline

Director Chemistry & Bioconjugation
March 1, 2024 - present
Head Of Chemistry
January, 2020

A panel showing how The Org can help with contacting the right person.